Motus GI Holdings (Motus GI Holdings) FCF Margin % : -2,900.00% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Motus GI Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Motus GI Holdings's Free Cash Flow for the three months ended in Dec. 2023 was $-1.86 Mil. Motus GI Holdings's Revenue for the three months ended in Dec. 2023 was $0.06 Mil. Therefore, Motus GI Holdings's FCF Margin % for the quarter that ended in Dec. 2023 was -2,900.00%.

As of today, Motus GI Holdings's current FCF Yield % is -2,973.16%.

The historical rank and industry rank for Motus GI Holdings's FCF Margin % or its related term are showing as below:

MOTS' s FCF Margin % Range Over the Past 10 Years
Min: -43000 Med: -10619.15 Max: -2988.34
Current: -3541.69

During the past 9 years, the highest FCF Margin % of Motus GI Holdings was -2988.34%. The lowest was -43000.00%. And the median was -10619.15%.

MOTS's FCF Margin % is ranked worse than
95.75% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: -7.275 vs MOTS: -3541.69

Motus GI Holdings FCF Margin % Historical Data

The historical data trend for Motus GI Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Motus GI Holdings FCF Margin % Chart

Motus GI Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-19,049.53

-17,429.59

-3,808.70

-2,988.34

-3,541.69

Motus GI Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-3,712.84	-8,644.64	-2,318.58	-2,303.49	-2,900.00

Competitive Comparison of Motus GI Holdings's FCF Margin %

For the Medical Devices subindustry, Motus GI Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Motus GI Holdings's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Motus GI Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Motus GI Holdings's FCF Margin % falls into.

Motus GI Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Motus GI Holdings's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-11.298	/	0.319
	=	-3,541.69 %

Motus GI Holdings's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.856	/	0.064
	=	-2,900.00 %

Motus GI Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Motus GI Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Motus GI Holdings (Motus GI Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Motus GI Holdings Inc (OTCPK:MOTS) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1301 East Broward Boulevard, 3rd Floor, Fort Lauderdale, FL, USA, 33301

Website

https://www.motusgi.com

Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the "FDA") to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal ("GI") endoscopy procedures. The Pure-Vu System is also CE marked in the European Economic Area (EEA) for use in colonoscopy.

Executives

Orchestra Biomed Holdings, Inc.	10 percent owner	150 UNION SQUARE DRIVE, NEW HOPE PA 18938
Scott Durbin	director	PO BOX 376, ANN ARBOR MI 48106
Elad Amor	officer: Chief Accounting Officer	MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FORT LAUDERDALE FL 33301
Ravit Ram	officer: Chief Financial Officer	MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FORT LAUDERDALE FL 33301
Timothy P. Moran	director, officer: Chief Executive Officer	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Andrew Lawrence Taylor	officer: Chief Financial Officer	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Mark Pomeranz	director, officer: President and COO	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Sonja Nelson	director	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BOULEVARD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Oracle Partners Lp	other: * See Remarks	200 GREENWICH AVE, 3RD FL, GREENWICH CT 06830
Larry N Feinberg	other: * See Remarks	C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
Perceptive Life Sciences Master Fund Ltd	10 percent owner	C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Darren Sherman	director	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
David P Hochman	director, other: Chairman of the Board	15 WESTON HILL RD., RIVERSIDE CT 06878
Nussbaum Samuel R Md	director	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Shervin J Korangy	director	850 PARK AVENUE, APT. 12B, NEW YORK NY 10075